NASDAQ:IMRN - IMMURON LTD/S News Headlines

Sign in or create an account to add this stock to your watchlist.
$5.60 +0.05 (+0.90 %)
(As of 04/26/2019 10:15 AM ET)
Previous Close$5.55
Today's Range$5.3366 - $5.60
52-Week Range$4.85 - $14.29
Volume874 shs
Average Volume4,778 shs
Market Capitalization$19.99 million
P/E RatioN/A
Dividend YieldN/A
Beta2.32

Headlines

IMMURON LTD/S (NASDAQ IMRN) News Headlines

Source:
DateHeadline
Immuron Appoints CEO Dr. Gary S. Jacob to Board of DirectorsImmuron Appoints CEO Dr. Gary S. Jacob to Board of Directors
finance.yahoo.com - April 17 at 10:58 AM
Do Institutions Own Immuron Limited (ASX:IMC) Shares?Do Institutions Own Immuron Limited (ASX:IMC) Shares?
finance.yahoo.com - April 16 at 10:40 AM
Immuron sales surge by 66% in the Third Quarter of FY19Immuron sales surge by 66% in the Third Quarter of FY19
finance.yahoo.com - April 15 at 10:45 AM
Contrasting TG Therapeutics (TGTX) and IMMURON LTD/S (IMRN)Contrasting TG Therapeutics (TGTX) and IMMURON LTD/S (IMRN)
www.americanbankingnews.com - April 14 at 2:18 PM
Zacks: IMMURON LTD/S (IMRN) Receives Consensus Rating of "Strong Buy" from AnalystsZacks: IMMURON LTD/S (IMRN) Receives Consensus Rating of "Strong Buy" from Analysts
www.americanbankingnews.com - April 12 at 2:19 AM
Immuron nabs U.S. patent for C. diff treatment; shares up 16%Immuron nabs U.S. patent for C. diff treatment; shares up 16%
seekingalpha.com - April 11 at 6:06 PM
Immuron Aims to Secure FDA Approval for IMM-124E to Prevent Travelers’ DiarrheaImmuron Aims to Secure FDA Approval for IMM-124E to Prevent Travelers’ Diarrhea
finance.yahoo.com - April 11 at 11:07 AM
Immuron Receives U.S. Patent on Drug Composition to Treat Clostridium difficileImmuron Receives U.S. Patent on Drug Composition to Treat Clostridium difficile
finance.yahoo.com - April 11 at 11:07 AM
What You Must Know About Immuron Limited’s (ASX:IMC) Financial StrengthWhat You Must Know About Immuron Limited’s (ASX:IMC) Financial Strength
finance.yahoo.com - February 12 at 9:55 AM
Travelan® FY19 1st Half Update and Geographic Expansion into North AmericaTravelan® FY19 1st Half Update and Geographic Expansion into North America
finance.yahoo.com - January 29 at 9:44 AM
Immuron Receives $1.19M R&D Tax Concession RefundImmuron Receives $1.19M R&D Tax Concession Refund
finance.yahoo.com - January 8 at 9:43 AM
One Thing To Remember About The Immuron Limited (ASX:IMC) Share PriceOne Thing To Remember About The Immuron Limited (ASX:IMC) Share Price
finance.yahoo.com - November 27 at 10:12 AM
Immuron Appoints Gary S. Jacob, Ph.D., Experienced US Based Biotechnology Executive, as CEOImmuron Appoints Gary S. Jacob, Ph.D., Experienced US Based Biotechnology Executive, as CEO
finance.yahoo.com - November 19 at 9:24 AM
NASH clinical trial presentation and continued revenue growthNASH clinical trial presentation and continued revenue growth
finance.yahoo.com - November 9 at 9:45 AM
Could Immuron Limited’s (ASX:IMC) Investor Composition Impacts Your Returns?Could Immuron Limited’s (ASX:IMC) Investor Composition Impacts Your Returns?
finance.yahoo.com - September 25 at 9:32 AM
US Department of Defense Reports Travelan Protects Against Shigella in PrimatesUS Department of Defense Reports Travelan Protects Against Shigella in Primates
finance.yahoo.com - September 5 at 4:13 PM
Immuron Reports Record Revenue Exceeding AU$2 million for the FY18 yearImmuron Reports Record Revenue Exceeding AU$2 million for the FY18 year
finance.yahoo.com - July 25 at 4:13 PM
US Department of Defense Research Collaboration Moves ForwardUS Department of Defense Research Collaboration Moves Forward
finance.yahoo.com - July 24 at 10:00 AM
Immuron Announces it has Received a European Patent Grant for NASH treatmentImmuron Announces it has Received a European Patent Grant for NASH treatment
finance.yahoo.com - July 24 at 10:00 AM
Immuron Announces Board AppointmentImmuron Announces Board Appointment
finance.yahoo.com - July 9 at 4:14 PM
Immuron Announces A$5.1M Private Placement to U.S. FundImmuron Announces A$5.1M Private Placement to U.S. Fund
finance.yahoo.com - March 14 at 10:45 AM
Immuron Progresses Discussions with Institutional FundsImmuron Progresses Discussions with Institutional Funds
finance.yahoo.com - March 13 at 10:02 AM
Your Daily Pharma Scoop: Immuron Surges, MyoKardia Results, Voyager Reports Longer-Term Data For VY-AADCYour Daily Pharma Scoop: Immuron Surges, MyoKardia Results, Voyager Reports Longer-Term Data For VY-AADC
seekingalpha.com - March 10 at 5:07 PM
Immuron Limited Issues Correction to Misleading Halt Announcement HeadlineImmuron Limited Issues Correction to Misleading Halt Announcement Headline
finance.yahoo.com - March 8 at 10:05 AM
Immuron Reports Positive Results in NASH Clinical TrialImmuron Reports Positive Results in NASH Clinical Trial
finance.yahoo.com - March 8 at 10:05 AM
Travelan® Revenue Grows Significantly in US and AustraliaTravelan® Revenue Grows Significantly in US and Australia
finance.yahoo.com - February 16 at 4:26 PM
Immuron Enrols First Patients in Clinical Study of IMM-529 for Treatment of Clostridium Difficile Infection (CDI)Immuron Enrols First Patients in Clinical Study of IMM-529 for Treatment of Clostridium Difficile Infection (CDI)
finance.yahoo.com - January 31 at 4:39 PM
US Defense Reports Broad Travelan® Reactivity to 180 Pathogenic Bacteria Including Camylobacter and ShigellaUS Defense Reports Broad Travelan® Reactivity to 180 Pathogenic Bacteria Including Camylobacter and Shigella
finance.yahoo.com - January 29 at 4:33 PM
Immuron to Receive $2.16M R&D Tax Concession RefundImmuron to Receive $2.16M R&D Tax Concession Refund
finance.yahoo.com - January 24 at 4:55 PM
CEO to Present on US Investor TV Show and at Biotech ConferenceCEO to Present on US Investor TV Show and at Biotech Conference
finance.yahoo.com - January 10 at 9:04 AM
Immuron to Present at RedChip’s Global Online Growth ConferenceImmuron to Present at RedChip’s Global Online Growth Conference
finance.yahoo.com - December 6 at 9:08 AM
Van Leeuwenhoeck Institute Updates Immuron Research CoverageVan Leeuwenhoeck Institute Updates Immuron Research Coverage
finance.yahoo.com - November 23 at 2:19 AM
Immuron Granted US Patent for NASH TreatmentImmuron Granted US Patent for NASH Treatment
finance.yahoo.com - November 17 at 6:33 AM
Immuron Successfully Completes NASH Phase II Clinical Study MilestoneImmuron Successfully Completes NASH Phase II Clinical Study Milestone
finance.yahoo.com - November 11 at 12:12 PM
Travelan Experiences Strong Q1 FY2018 Sales GrowthTravelan Experiences Strong Q1 FY2018 Sales Growth
finance.yahoo.com - November 8 at 10:17 AM
Immuron Commences US Non-Deal Institutional Investor RoadshowImmuron Commences US Non-Deal Institutional Investor Roadshow
finance.yahoo.com - September 19 at 7:56 PM
Immuron Highlights Recent Milestones in Quest to Effectively Treat Multiple Forms of Fatty Liver Diseases That Impact MillionsImmuron Highlights Recent Milestones in Quest to Effectively Treat Multiple Forms of Fatty Liver Diseases That Impact Millions
finance.yahoo.com - September 19 at 7:56 PM
Immuron Approved to Commence Clinical Study in C.Difficile Infection (CDI)Immuron Approved to Commence Clinical Study in C.Difficile Infection (CDI)
finance.yahoo.com - August 9 at 8:07 PM
NASH Phase II Interim Analysis Reveals Improvement in Liver Enzymes (AST and ALT) with Good Safety and TolerabilityNASH Phase II Interim Analysis Reveals Improvement in Liver Enzymes (AST and ALT) with Good Safety and Tolerability
finance.yahoo.com - July 10 at 7:51 PM
This page was last updated on 4/26/2019 by MarketBeat.com Staff

Featured Article: Buyback

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel